Evidence map›Paper›PMID 19720052›Full record

ArticleBiochemical and biophysical research communications2009

Identification of X-DING-CD4, a new member of human DING protein family that is secreted by HIV-1 resistant CD4(+) T cells and has anti-viral activity.

Adam Lesner, Rasheda Shilpi, Anna Ivanova, Mary Ann Gawinowicz, Jacob Lesniak, Dimitar Nikolov, Malgorzata Simm

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. DING Proteins Extend to the Extremophilic World.International journal of molecular sciences · 2021
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. DING proteins: numerous functions, elusive genes, a potential for health.Cellular and molecular life sciences : CMLS · 2013
    Review
  11. Article
  12. Crystallization and preliminary X-ray diffraction analysis of a DING protein from Pseudomonas aeruginosa PA14.Acta crystallographica. Section F, Structural biology and crystallization communications · 2013
    Article
  13. Article
  14. Article
  15. Article
  16. Achieving a cure for HIV infection: do we have reasons to be optimistic?The Journal of antimicrobial chemotherapy · 2012
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Adam LesnerProtein Chemistry Laboratory, St. Luke's/Roosevelt Institute for Health Sciences, Columbia University, New York, NY 10019, USA.
Rasheda Shilpi
Anna Ivanova
Mary Ann Gawinowicz
Jacob Lesniak
Dimitar Nikolov
Malgorzata Simm
St. Luke's-Roosevelt Hospital Center · USMemorial Sloan Kettering Cancer Center · USColumbia University · USRoosevelt Institute · US

Funding

CTCF peptides - a new therapeutic alternative to target HIV in the brain.R01NS062649 · NINDS · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI SIMM, MALGORZATA · 2008 to 2012
$2.0M
HRF, an NFkB antagonist targeting multiple pathogenesU01AI061286 · NIAID · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI SIMM, MALGORZATA · 2005 to 2008
$1.2M
Inducible Cellular Resistance to HIV-1 infection.R01AI048388 · NIAID · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI SIMM, MALGORZATA · 2001 to 2003
$810k
NIAID NIH HHS AI061286NIAID NIH HHS AI48388NIAID NIH HHS R01 AI048388NIAID NIH HHS U01 AI061286NINDS NIH HHS R01 NS062649
6 · The paper itself

Abstract

We reported previously the anti-viral activity named HRF (HIV-1 Resistance Factor) secreted by HIV-1 resistant cells. This work describes the identification of HRF from cell culture supernatant of HRF-producing cells (HRF(+) cells). Employing the proteomics and cell based activity assay we recovered ten peptides sharing 80-93% sequence homology with other eukaryotic DING proteins; discrete amino acid characteristics found in our material suggested that HRF is a new member of DING proteins family and consequently we designated it as X-DING-CD4 (extracellular DING from CD4(+) T cells). The presence of X-DING-CD4 in the extracellular compartment of HRF(+) but not control HRF(-) cells was confirmed by specific anti-X-DING-CD4 antibody. Similar as the un-fractionated HRF(+) cell culture supernatant, the purified X-DING-CD4 blocked transcription of HIV-1 LTR-promoted expression of luciferase gene and replication of HIV-1 in MAGI cells. The X-DING-CD4 -mediated anti-viral activity in MAGI cells could be blocked by specific antibody.

Indexed as

Amino Acid SequenceCarrier ProteinsCD4-Positive T-LymphocytesCell LineDNA-Binding ProteinsHIV-1HumansMolecular Sequence DataPolycomb Repressive Complex 1Ubiquitin-Protein LigasesCarrier ProteinsDNA-Binding ProteinsPolycomb Repressive Complex 1RNF2 protein, humanUbiquitin-Protein LigasesX-DING-CD4 protein, human

Identifiers

PMID19720052
PMCPMC2957897
OpenAlexW2047620019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.